Eyenovia Rocketed by Groundbreaking $50M Crypto Deal and Validator Node Ambitions

Eyenovia’s daring pivot from pharmaceuticals to crypto raises eyebrows—will their $50M gamble on HYPE tokens lead to unprecedented growth or a costly misstep?